Literature DB >> 19014377

Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration.

D Gómez-Nicola1, B Valle-Argos, M Suardíaz, J S Taylor, M Nieto-Sampedro.   

Abstract

The release of inflammatory mediators from immune and glial cells either in the peripheral or CNS may have an important role in the development of physiopathological processes such as neuropathic pain. Microglial, then astrocytic activation in the spinal cord, lead to chronic inflammation, alteration of neuronal physiology and neuropathic pain. Standard experimental models of neuropathic pain include an important peripheral inflammatory component, which involves prominent immune cell activation and infiltration. Among potential immunomodulators, the T-cell cytokine interleukin-15 (IL-15) has a key role in regulating immune cell activation and glial reactivity after CNS injury. Here we show, using the model of chronic constriction of the sciatic nerve (CCI), that IL-15 is essential for the development of the early inflammatory events in the spinal cord after a peripheral lesion that generates neuropathic pain. IL-15 expression in the spinal cord was identified in both astroglial and microglial cells and was present during the initial gliotic and inflammatory (NFkappaB) response to injury. The expression of IL-15 was also identified as a cue for macrophage and T-cell activation and infiltration in the sciatic nerve, as shown by intraneural injection of the cytokine and activity blockage approaches. We conclude that the regulation of IL-15 and hence the initial events following its expression after peripheral nerve injury could have a future therapeutic potential in the reduction of neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19014377     DOI: 10.1111/j.1471-4159.2008.05746.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

Review 1.  Osteoarthritis joint pain: the cytokine connection.

Authors:  Rachel E Miller; Richard J Miller; Anne-Marie Malfait
Journal:  Cytokine       Date:  2014-07-24       Impact factor: 3.861

2.  Glial NF-κB inhibition alters neuropeptide expression after sciatic nerve injury in mice.

Authors:  Yan Ping Zhang; Eugene S Fu; Jacqueline Sagen; Roy C Levitt; Keith A Candiotti; John R Bethea; Roberta Brambilla
Journal:  Brain Res       Date:  2011-02-23       Impact factor: 3.252

3.  Glioma growth inhibition by neurostatin and O-But GD1b.

Authors:  Beatriz Valle-Argos; Diego Gómez-Nicola; Manuel Nieto-Sampedro
Journal:  Neuro Oncol       Date:  2010-07-08       Impact factor: 12.300

4.  Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.

Authors:  Emanuela Esposito; Stefano Bruscoli; Emanuela Mazzon; Irene Paterniti; Maddalena Coppo; Enrico Velardi; Salvatore Cuzzocrea; Carlo Riccardi
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

5.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Authors:  Manuel Nieto-Sampedro; Beatriz Valle-Argos; Diego Gómez-Nicola; Alfonso Fernández-Mayoralas; Manuel Nieto-Díaz
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

6.  Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints.

Authors:  Xin Li; Jeffrey S Kroin; Ranjan Kc; Gary Gibson; Di Chen; Grant T Corbett; Kalipada Pahan; Sana Fayyaz; Jae-Sung Kim; Andre J van Wijnen; Joon Suh; Su-Gwan Kim; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

Review 7.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

8.  Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration.

Authors:  Ryan Gene Soderquist; Evan M Sloane; Lisa C Loram; Jacqueline A Harrison; Ellen C Dengler; Scott M Johnson; Luke D Amer; Courtney S Young; Makenzie T Lewis; Stephen Poole; Matthew G Frank; Linda R Watkins; Erin D Milligan; Melissa J Mahoney
Journal:  Pharm Res       Date:  2010-03-12       Impact factor: 4.200

9.  Human Prostate Cancer Cells Secrete Neuro-Protective Factors in Response to Cryotherapy.

Authors:  Seema Gupta; Mini Varghese; Mohammed M Shareef; Mansoor M Ahmed
Journal:  Mol Cell Pharmacol       Date:  2009-01-01

10.  Interactions between the immune and nervous systems in pain.

Authors:  Ke Ren; Ronald Dubner
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.